AAQL
Antiaging Quantum Living Inc.0.5911
+0.0000+0%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
20.26MP/E (TTM)
-Basic EPS (TTM)
-0.02Dividend Yield
0%Recent Filings
10-Q
10-Q
Q2 FY2026 results
Antiaging Quantum Living posted Q2 FY2026 revenue of $291K, up 44% y/y from $202K, driven entirely by technical operation support and maintenance services, while gross margin slipped to 80.5% from 99.9% on higher costs. Operating loss narrowed to $138K from $214K y/y, thanks to 10% lower expenses like wages and fees, yielding a net loss of $133K versus $214K last year; diluted EPS improved to $(0.0045) across 30M shares. Cash climbed to $406K on $220K related-party funding, though operations burned $185K and long-term related-party debt sits at $1.7M, non-interest-bearing through 2029. No non-GAAP metrics disclosed in the 10-Q. Reliance on one customer spells trouble.
10-K
FY2025 results
Antiaging Quantum Living Inc. posted FY2025 revenue of $817,898, up 10,806.8% y/y from $7,499, driven entirely by new online platform technical support and maintenance services while prior health product sales and advertising vanished. Gross profit hit $428,517 at 52.4% margin, but operating expenses tripled to $1,218,476 on expansion costs like rentals and wages, yielding an operating loss of $789,959 and net loss of $720,409, or $(0.0240) per diluted share on 29,995,000 shares. Q4 momentum faltered amid heavy startup outlays, though cash swelled to $370,549 via $1.17M in related-party financing, with $1.28M debt converted to long-term notes. No quarterly breakdowns disclosed. Dependence on one customer risks revenue cliff.
10-Q
Q3 FY2025 results
Antiaging Quantum Living Inc. ramped up revenue to $154K in Q3 FY2025 ended December 31, 2024, a sharp 2352% y/y jump from $6K, driven by new technical support services while costs held at 3.3% of sales for a solid gross margin. Yet operating expenses ballooned to $348K from $103K y/y, fueled by rentals and wages for expansion, yielding an operating loss of $199K versus $97K last year; net loss widened to $129K after a $70K renovation subsidy offset some pain. For the nine months, revenue hit $530K (6964% y/y growth) against a $541K net loss, with EPS at $(0.018) aligning to 30M diluted shares. Cash climbed to $202K, backed by $1.7M in non-interest-bearing notes due 2029 from related parties and third parties, while FCF isn't disclosed in the 10-Q. Revenue now flows from Asia-Pacific platforms. Competition in health tech markets poses ongoing pressure.
10-Q
Q2 FY2025 results
Antiaging Quantum Living ramped up revenue to $173K in Q2 FY2025 ended September 30, 2024, a leap from zero last year, driven by $124K in health and beauty product sales and $252K YTD from technical support services—yet operating expenses surged 1,363% y/y to $357K on rentals, wages, and startup costs like cloud hosting. This fueled a $198K operating loss, widening 711% y/y, with net loss matching at $198K since no taxes hit; EPS fell to $(0.0066) on 30M shares. Cash dwindled to $37K after $223K operating outflow, offset by $139K related-party advances, while $431K third-party debt matures in 2026 interest-free. Shareholders' deficit deepened to $842K. Still, revenue momentum hints at traction. Competition in e-commerce platforms poses a key risk.
ARQQ
Arqit Quantum Inc.
24.73+0.38
CHWY
Chewy, Inc.
33.34+0.20
DIBS
1stdibs.com, Inc.
5.92+0.01
MDCE
Medical Care Technologies Inc.
0.00-0.00
PDD
PDD Holdings Inc.
109.02-1.38
PTRN
Pattern Group Inc. - Series A
11.88+0.01
QS
QuantumScape Corporation
10.84+0.01
RERE
ATRenew Inc.
5.22-0.03
WBUY
WEBUY GLOBAL LTD.
1.79+0.01
YJ
Yunji Inc. - American Depositor
1.40-0.09